Lenalidomide also enhanced the antigen-specific secretion of Granzyme B in HDs (p = 0.028, Figure 1C) and patients with plasma cell dyscrasia (PD) (p ≤ 0.001, Figure 1D). This evidence concerns the gene GZMB and plasma cell neoplasm.